{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T12:14:54Z","timestamp":1785240894746,"version":"3.55.0"},"reference-count":40,"publisher":"Editorial Committee of Japanese Journal of Infectious Diseases, National Institute of Infectious Dis","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jpn J Infect Dis"],"published-print":{"date-parts":[[2023,3,31]]},"DOI":"10.7883\/yoken.jjid.2022.484","type":"journal-article","created":{"date-parts":[[2022,11,30]],"date-time":"2022-11-30T06:36:40Z","timestamp":1669790200000},"page":"126-134","source":"Crossref","is-referenced-by-count":5,"title":["Molecular Epidemiology of Penicillinase-Producing &lt;i&gt;Neisseria gonorrhoeae&lt;\/i&gt; Isolates and Their &lt;i&gt;bla&lt;\/i&gt;&lt;sub&gt;TEM-135&lt;\/sub&gt; Gene Variant in Bangkok, Thailand, 2015\u20132017"],"prefix":"10.7883","volume":"76","author":[{"given":"Natakorn","family":"Nokchan","sequence":"first","affiliation":[{"name":"Department of Microbiology, Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Perapon","family":"Nitayanon","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chanwit","family":"Tribuddharat","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4631","reference":[{"key":"1","unstructured":"1. World Health Organization (WHO). Global progress report on HIV, viral hepatitis and sexually transmitted infections, 2021. Available at &lt;https:\/\/www.who.int\/publications\/i\/item\/9789240027077&gt;. Accessed July 9, 2022."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Li X, Le W, Lou X, et al. <i>In vitro<\/i> efficacy of gentamicin alone and in combination with ceftriaxone, ertapenem, and azithromycin against multidrug-resistant <i>Neisseria gonorrhoeae<\/i>. Microbiol Spectr. 2021;9:e0018121.","DOI":"10.1128\/Spectrum.00181-21"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Eyre DW, Sanderson ND, Lord E, et al. Gonorrhoea treatment failure caused by a <i>Neisseria gonorrhoeae<\/i> strain with combined ceftriaxone and high-level azithromycin resistance, England, February 2018. Euro Surveill. 2018;23:1800323.","DOI":"10.2807\/1560-7917.ES.2018.23.27.1800323"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Pleininger S, Indra A, Golparian D, et al. Extensively drug-resistant (XDR) <i>Neisseria gonorrhoeae<\/i> causing possible gonorrhoea treatment failure with ceftriaxone plus azithromycin in Austria, April 2022. Euro Surveill. 2022;27:2200455.","DOI":"10.2807\/1560-7917.ES.2022.27.24.2200455"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Unemo M, Shafer WM. Antimicrobial resistance in <i>Neisseria gonorrhoeae<\/i> in the 21st century: past, evolution, and future. Clin Microbiol Rev. 2014;27:587-613.","DOI":"10.1128\/CMR.00010-14"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Crum JW, Duangmani C, Vibulyasekha S, et al. Resistance to penicillin and identification of penicillinase-producing <i>Neisseria gonorrhoeae<\/i> among clinical isolates in Thailand. Antimicrob Agents Chemother. 1980;18:360-361.","DOI":"10.1128\/AAC.18.2.360"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Nokchan N, Wongsurawat T, Jenjaroenpun P, et al. Whole-genome sequence analysis of high-level penicillin-resistant strains and antimicrobial susceptibility of <i>Neisseria gonorrhoeae<\/i> clinical isolates from Thailand. PLoS One. 2022;17:e0271657.","DOI":"10.1371\/journal.pone.0271657"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Whiley D, Trembizki E, Buckley C, et al. Penicillinase-producing plasmid types in <i>Neisseria gonorrhoeae<\/i> clinical isolates from Australia. Antimicrob Agents Chemother. 2014;58:7576-7578.","DOI":"10.1128\/AAC.04120-14"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Srifeungfung S, Roongpisuthipong A, Asavapiriyanont S, et al. Prevalence of <i>Chlamydia trachomatis<\/i> and <i>Neisseria gonorrhoeae<\/i> in HIV-seropositive patients and gonococcal antimicrobial susceptibility: an update in Thailand. Jpn J Infect Dis. 2009;62:467-470.","DOI":"10.7883\/yoken.JJID.2009.467"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Naas T, Oueslati S, Bonnin RA, et al. Beta-lactamase database (BLDB) - structure and function. J Enzyme Inhib Med Chem. 2017;32:917-919.","DOI":"10.1080\/14756366.2017.1344235"},{"key":"11","unstructured":"11. Bureau of AIDS, TB and STIs, Department of Disease Control, Ministry of Public Health of Thailand. Guidelines for the treatment of gonococcal infections 2019. 1st ed. Bangkok, Thailand: Bangrak STIs Cluster; 2019. Available at &lt;http:\/\/utoapp.moph.go.th\/e_doc\/views\/uploads\/5e4cbc41b41a7-02413010285f714b066770cc26dc5677-779.pdf&gt;. Thai language."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Tribuddharat C, Pongpech P, Charoenwatanachokchai A, et al. Gonococcal antimicrobial susceptibility and the prevalence of <i>bla<\/i><sub>TEM-1<\/sub> and <i>bla<\/i><sub>TEM-135<\/sub> genes in <i>Neisseria gonorrhoeae<\/i> isolates from Thailand. Jpn J Infect Dis. 2017;70:213-215.","DOI":"10.7883\/yoken.JJID.2016.209"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Muhammad I, Golparian D, Dillon J-AR, et al. Characterisation of <i>bla<\/i><sub>TEM<\/sub> genes and types of \u03b2-lactamase plasmids in <i>Neisseria gonorrhoeae<\/i> - the prevalent and conserved <i>bla<\/i><sub>TEM-135<\/sub> has not recently evolved and existed in the Toronto plasmid from the origin. BMC Infect Dis. 2014;14:454.","DOI":"10.1186\/1471-2334-14-454"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Martin IMC, Ison CA, Aanensen DM, et al. Rapid sequence-based identification of gonococcal transmission clusters in a large metropolitan area. J Infect Dis. 2004;189:1497-1505.","DOI":"10.1086\/383047"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Nakayama S-I, Tribuddharat C, Prombhul S, et al. Molecular analyses of TEM genes and their corresponding penicillinase-producing <i>Neisseria gonorrhoeae<\/i> isolates in Bangkok, Thailand. Antimicrob Agents Chemother. 2012;56:916-920.","DOI":"10.1128\/AAC.05665-11"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Jolley KA, Maiden MCJ. BIGSdb: Scalable analysis of bacterial genome variation at the population level. BMC Bioinformatics. 2010;11:595.","DOI":"10.1186\/1471-2105-11-595"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Cherdtrakulkiat T, Wongsurawat T, Jenjaroenpun P, et al. Complete genome sequences of three <i>Neisseria gonorrhoeae<\/i> isolates from Thailand with multidrug resistance and multilocus sequence type 1903. Microbiol Resour Announc. 2020;9:e00198-20.","DOI":"10.1128\/MRA.00198-20"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Yan J, Zhang J, van der Veen S. High prevalence of TEM-135 expression from the Asian plasmid in penicillinase-producing <i>Neisseria gonorrhoeae<\/i> from Hangzhou, China. Int J Antimicrob Agents. 2019;54:361-366.","DOI":"10.1016\/j.ijantimicag.2019.06.012"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Gianecini R, Oviedo C, Littvik A, et al. Identification of TEM-135 \u03b2-lactamase in <i>Neisseria gonorrhoeae<\/i> strains carrying African and Toronto plasmids in Argentina. Antimicrob Agents Chemother. 2015;59:717-720.","DOI":"10.1128\/AAC.03838-14"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Attram N, Agbodzi B, Dela H, et al. Antimicrobial resistance (AMR) and molecular characterization of <i>Neisseria gonorrhoeae<\/i> in Ghana, 2012\u20132015. PLoS One. 2019;14:e0223598.","DOI":"10.1371\/journal.pone.0223598"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. S\u00e1nchez-Bus\u00f3 L, Cole MJ, Spiteri G, et al. Europe-wide expansion and eradication of multidrug-resistant <i>Neisseria gonorrhoeae<\/i> lineages: a genomic surveillance study. Lancet Microbe. 2022;3:e452-e463.","DOI":"10.1016\/S2666-5247(22)00044-1"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Wind CM, Bruisten SM, Schim van der Loeff MF, et al. A case-control study of molecular epidemiology in relation to azithromycin resistance in <i>Neisseria gonorrhoeae<\/i> isolates collected in Amsterdam, the Netherlands, between 2008 and 2015. Antimicrob Agents Chemother. 2017;61:e02374-16.","DOI":"10.1128\/AAC.02374-16"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Palmer HM, Leeming JP, Turner A. A multiplex polymerase chain reaction to differentiate \u03b2-lactamase plasmids of <i>Neisseria gonorrhoeae<\/i>. J Antimicrob Chemother. 2000;45:777-782.","DOI":"10.1093\/jac\/45.6.777"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Zhao R, Shi J, Shen Y, et al. Phylogenetic distribution of virulence genes among ESBL-producing uropathogenic <i>Escherichia coli <\/i>isolated from long-term hospitalized patients. J Clin Diagn Res. 2015;9:DC01-DC04.","DOI":"10.7860\/JCDR\/2015\/13234.6157"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Golparian D, Kittiyaowamarn R, Paopang P, et al. Genomic surveillance and antimicrobial resistance in <i>Neisseria gonorrhoeae<\/i> isolates in Bangkok, Thailand in 2018. J Antimicrob Chemother. 2022;77:2171-2182.","DOI":"10.1093\/jac\/dkac158"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Kandinov I, Dementieva E, Kravtsov D, et al. Molecular typing of <i>Neisseria gonorrhoeae<\/i> clinical isolates in Russia, 2018\u20132019: a link between <i>penA<\/i> alleles and NG-MAST types. Pathogens. 2020;9:941.","DOI":"10.3390\/pathogens9110941"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Liao M, Gu W-M, Yang Y, et al. Analysis of mutations in multiple loci of <i>Neisseria gonorrhoeae<\/i> isolates reveals effects of PIB, PBP2 and MtrR on reduced susceptibility to ceftriaxone. J Antimicrob Chemother. 2011;66:1016-1023.","DOI":"10.1093\/jac\/dkr021"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Singh AE, Gratrix J, Read R, et al. <i>Neisseria gonorrhoeae<\/i> multiantigen sequence typing is beneficial in further characterizing gonococcal populations in Alberta, Canada. Sex Transm Dis. 2013;40:744-750.","DOI":"10.1097\/01.olq.0000431356.80840.d4"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Banhart S, Jansen K, Buder S, et al. Molecular epidemiological typing of <i>Neisseria gonorrhoeae<\/i> isolates identifies a novel association between genogroup G10557 (G7072) and decreased susceptibility to cefixime, Germany, 2014 to 2017. Euro Surveill. 2020;25:1900648.","DOI":"10.2807\/1560-7917.ES.2020.25.41.1900648"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Yuchui N, Boonbumrung K. Molecular epidemiological typing and antimicrobial resistance of <i>Neisseria gonorrhoeae<\/i> strains in Thailand. P2-CE07, Abstract of the 4th International Interscience Conference of Infection and Chemotherapy and 12th International Symposium on Antimicrobial Agents and Resistance, Gyeongju, Korea, September 26-28, 2019. Infect Chemother. 2019;51:S154. Available at &lt;https:\/\/icjournal.org\/src\/sm\/ic-51-S1-s005.pdf&gt;.","DOI":"10.3947\/ic.2019.51.Suppl1"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Chen S-C, Han Y, Yuan L-F, et al. Identification of internationally disseminated ceftriaxone-resistant <i>Neisseria gonorrhoeae<\/i> strain FC428, China. Emerg Infect Dis. 2019;25:1427-1429.","DOI":"10.3201\/eid2507.190172"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Unemo M, Golparian D, Nicholas R, et al. High-level cefixime- and ceftriaxone-resistant <i>Neisseria gonorrhoeae<\/i> in France: novel <i>penA<\/i> mosaic allele in a successful international clone causes treatment failure. Antimicrob Agents Chemother. 2012;56:1273-1280.","DOI":"10.1128\/AAC.05760-11"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Horn NN, Kresken M, K\u00f6rber-Irrgang B, et al. Antimicrobial susceptibility and molecular epidemiology of <i>Neisseria gonorrhoeae<\/i> in Germany. Int J Med Microbiol. 2014;304:586-591.","DOI":"10.1016\/j.ijmm.2014.04.001"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Straub C, Thirkell C, Tiong A, et al. The antimicrobial resistance landscape of <i>Neisseria gonorrhoeae<\/i> in New Zealand from November 2018 to March 2019 and the role of sexual orientation in transmission. Microb Genom. 2021;7:000701.","DOI":"10.1099\/mgen.0.000701"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Shaskolskiy B, Dementieva E, Kandinov I, et al. Resistance of <i>Neisseria gonorrhoeae<\/i> isolates to beta-lactam antibiotics (benzylpenicillin and ceftriaxone) in Russia, 2015\u20132017. PLoS One. 2019;14:e0220339.","DOI":"10.1371\/journal.pone.0220339"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Chen S-C, Yin Y-P, Dai X-Q, et al. Prevalence and molecular epidemiological typing of penicillinase-producing <i>Neisseria gonorrhoeae<\/i> and their <i>bla<\/i><sub>TEM-135<\/sub> gene variants in Nanjing, China. Sex Transm Dis. 2013;40:872-876.","DOI":"10.1097\/OLQ.0000000000000037"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Mica\u00eblo M, Goubard A, La Ruche G, et al. Molecular epidemiology of penicillinase-producing <i>Neisseria gonorrhoeae<\/i> isolates in France. Clin Microbiol Infect. 2017;23:968-973.","DOI":"10.1016\/j.cmi.2017.04.010"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Rim JH, Kim H, Lee H, et al. Recent increase in the incidence of TEM-135 \u03b2-lactamase-harboring <i>Neisseria gonorrhoeae<\/i> in Korea. Ann Lab Med. 2018;38:324-330.","DOI":"10.3343\/alm.2018.38.4.324"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Palzkill T. Structural and mechanistic basis for extended-spectrum drug-resistance mutations in altering the specificity of TEM, CTX-M, and KPC \u03b2-lactamases. Front Mol Biosci. 2018;5:16.","DOI":"10.3389\/fmolb.2018.00016"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Sideraki V, Huang W, Palzkill T, et al. A secondary drug resistance mutation of TEM-1 beta-lactamase that suppresses misfolding and aggregation. Proc Natl Acad Sci USA. 2001;98:283-288.","DOI":"10.1073\/pnas.98.1.283"}],"container-title":["Japanese Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/yoken\/76\/2\/76_JJID.2022.484\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,25]],"date-time":"2023-03-25T04:16:26Z","timestamp":1679717786000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/yoken\/76\/2\/76_JJID.2022.484\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,31]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.7883\/yoken.jjid.2022.484","relation":{},"ISSN":["1344-6304","1884-2836"],"issn-type":[{"value":"1344-6304","type":"print"},{"value":"1884-2836","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,31]]},"article-number":"JJID.2022.484"}}